J7502 HCPCS code: Cyclosporine, oral, 100 mg
J7502 is the HCPCS Level II code for cyclosporine, oral, 100 mg. In 2024 Medicare paid an average of $1.72 per service for J7502 across 1,090,797 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 720 per day on DME suppliers. Medicare volume fell 13% from 2022 to 2024 (1,258,344 to 1,090,797 services). In 2024, 1,311 suppliers billed Medicare for J7502 (purchases), serving 2,463 beneficiaries; California, New York, Texas accounted for 28% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 57 |
| BETOS category | O1E — Other drugs |
| Added | 2000-01-01 |
| Last action effective | 2000-01-01 |
Who bills J7502 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 1,311 |
| Referring clinicians | 2,244 |
| Medicare beneficiaries | 2,463 |
| States with claims | 50 |
| Share of services in top 3 states (California, New York, Texas) | 28% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 1,469 | 2,742 |
| 2023 | 1,457 | 2,623 |
| 2024 | 1,311 | 2,463 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7502, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,258,344 | 2,742 | $2.15 | $1.62 |
| 2023 | 1,153,664 | 2,623 | $2.08 | $1.57 |
| 2024 | 1,090,797 | 2,463 | $2.28 | $1.72 |
States with the most J7502 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 118,490 | $1.72 |
| New York | 112,525 | $1.73 |
| Texas | 72,009 | $1.72 |
| Florida | 70,770 | $1.71 |
| Pennsylvania | 59,434 | $1.72 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 720 | CMS Policy |
| outpatient hospital claims | 60 | Clinical: Data |
What changed for J7502
- 2000-01-01: J7502 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7502?
J7502 is the HCPCS Level II code for cyclosporine, oral, 100 mg. Short descriptor: "Cyclosporine oral 100 mg".
How much does Medicare pay for J7502?
In 2024, the average Medicare payment was $1.72 per service (average allowed $2.28).
Does Medicare cover J7502?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J7502 can be billed per day?
720 on DME suppliers; 60 on outpatient hospital claims (NCCI medically unlikely edits).
Related J75 codes
- J7500 — Azathioprine, oral, 50 mg
- J7501 — Azathioprine, parenteral, 100 mg
- J7503 — Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504 — Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7505 — Muromonab-cd3, parenteral, 5 mg
- J7506 — Prednisone, oral, per 5 mg
- J7507 — Tacrolimus, immediate release, oral, 1 mg
- J7508 — Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
- J7509 — Methylprednisolone oral, per 4 mg
- J7510 — Prednisolone oral, per 5 mg
- J7511 — Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
- J7512 — Prednisone, immediate release or delayed release, oral, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7502
- Watch J7502 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7502
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.